118 related articles for article (PubMed ID: 37992567)
1. NEIL3 promotes cell proliferation of ccRCC via the cyclin D1-Rb-E2F1 feedback loop regulation.
Zhang M; Jiang Y; Wang J; Yue Y; Liu W; Wang L; Li Y; Wang W; Cai H; Yang Z; Ma M; Lu S; Fan J
DNA Repair (Amst); 2024 Jan; 133():103604. PubMed ID: 37992567
[TBL] [Abstract][Full Text] [Related]
2. PRR11 promotes ccRCC tumorigenesis by regulating E2F1 stability.
Chen S; He Z; Peng T; Zhou F; Wang G; Qian K; Ju L; Xiao Y; Wang X
JCI Insight; 2021 Oct; 6(19):. PubMed ID: 34499617
[TBL] [Abstract][Full Text] [Related]
3. LINC00511 promotes the malignant phenotype of clear cell renal cell carcinoma by sponging microRNA-625 and thereby increasing cyclin D1 expression.
Deng H; Huang C; Wang Y; Jiang H; Peng S; Zhao X
Aging (Albany NY); 2019 Aug; 11(16):5975-5991. PubMed ID: 31434797
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of E2F1 promotes tumor malignancy and correlates with TNM stages in clear cell renal cell carcinoma.
Ma X; Gao Y; Fan Y; Ni D; Zhang Y; Chen W; Zhang P; Song E; Huang Q; Ai Q; Li H; Wang B; Zheng T; Shi T; Zhang X
PLoS One; 2013; 8(9):e73436. PubMed ID: 24023875
[TBL] [Abstract][Full Text] [Related]
5. E2F1 promotes proliferation and metastasis of clear cell renal cell carcinoma via activation of SREBP1-dependent fatty acid biosynthesis.
Shen D; Gao Y; Huang Q; Xuan Y; Yao Y; Gu L; Huang Y; Zhang Y; Li P; Fan Y; Tang L; Du S; Wu S; Wang H; Wang C; Gong H; Pang Y; Ma X; Wang B; Zhang X
Cancer Lett; 2021 Aug; 514():48-62. PubMed ID: 34019961
[TBL] [Abstract][Full Text] [Related]
6. miR-218 suppresses gastric cancer cell cycle progression through the CDK6/Cyclin D1/E2F1 axis in a feedback loop.
Deng M; Zeng C; Lu X; He X; Zhang R; Qiu Q; Zheng G; Jia X; Liu H; He Z
Cancer Lett; 2017 Sep; 403():175-185. PubMed ID: 28634044
[TBL] [Abstract][Full Text] [Related]
7. Attenuation of krüppel-like factor 4 facilitates carcinogenesis by inducing g1/s phase arrest in clear cell renal cell carcinoma.
Song E; Ma X; Li H; Zhang P; Ni D; Chen W; Gao Y; Fan Y; Pang H; Shi T; Ding Q; Wang B; Zhang Y; Zhang X
PLoS One; 2013; 8(7):e67758. PubMed ID: 23861801
[TBL] [Abstract][Full Text] [Related]
8. Methylenetetrahydrofolate Dehydrogenase 1 (MTHFD1) is Underexpressed in Clear Cell Renal Cell Carcinoma Tissue and Transfection and Overexpression in Caki-1 Cells Inhibits Cell Proliferation and Increases Apoptosis.
He D; Yu Z; Liu S; Dai H; Xu Q; Li F
Med Sci Monit; 2018 Nov; 24():8391-8400. PubMed ID: 30459299
[TBL] [Abstract][Full Text] [Related]
9. Low level of Cyclin-D1 correlates with worse prognosis of clear cell renal cell carcinoma patients.
Wang QS; Li F; Liao ZQ; Li K; Yang XL; Lin YY; Zhao YL; Weng SY; Xia Y; Ye Y; Li SH; Wang CY; Lin Y
Cancer Med; 2019 Aug; 8(9):4100-4109. PubMed ID: 31183974
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of ERp57 promotes clear cell renal cell carcinoma progression by initiating a STAT3/ILF3 feedback loop.
Liu Y; Wang JX; Nie ZY; Wen Y; Jia XJ; Zhang LN; Duan HJ; Shi YH
J Exp Clin Cancer Res; 2019 Oct; 38(1):439. PubMed ID: 31747963
[TBL] [Abstract][Full Text] [Related]
11. G6PD upregulates Cyclin E1 and MMP9 to promote clear cell renal cell carcinoma progression.
Zhang Q; Ni Y; Wang S; Agbana YL; Han Q; Liu W; Bai H; Yi Z; Yi X; Zhu Y; Sai B; Yang L; Shi Q; Kuang Y; Yang Z; Zhu Y
Int J Med Sci; 2022; 19(1):47-64. PubMed ID: 34975298
[No Abstract] [Full Text] [Related]
12. Overexpression of COPS3 promotes clear cell renal cell carcinoma progression via regulation of Phospho-AKT(Thr308), Cyclin D1 and Caspase-3.
Hong Y; Huang X; An L; Ye H; Ma K; Zhang F; Xu Q
Exp Cell Res; 2018 Apr; 365(2):163-170. PubMed ID: 29477618
[TBL] [Abstract][Full Text] [Related]
13. KLF6 Suppresses Metastasis of Clear Cell Renal Cell Carcinoma via Transcriptional Repression of E2F1.
Gao Y; Li H; Ma X; Fan Y; Ni D; Zhang Y; Huang Q; Liu K; Li X; Wang L; Gu L; Yao Y; Ai Q; Du Q; Song E; Zhang X
Cancer Res; 2017 Jan; 77(2):330-342. PubMed ID: 27780824
[TBL] [Abstract][Full Text] [Related]
14. SOX6 represses tumor growth of clear cell renal cell carcinoma by HMG domain-dependent regulation of Wnt/β-catenin signaling.
Chen L; Xie Y; Ma X; Zhang Y; Li X; Zhang F; Gao Y; Fan Y; Gu L; Wang L; Zhang X; Fu B
Mol Carcinog; 2020 Oct; 59(10):1159-1173. PubMed ID: 32794610
[TBL] [Abstract][Full Text] [Related]
15. VHL mutation-mediated SALL4 overexpression promotes tumorigenesis and vascularization of clear cell renal cell carcinoma via Akt/GSK-3β signaling.
Sun J; Tang Q; Gao Y; Zhang W; Zhao Z; Yang F; Hu X; Zhang D; Wang Y; Zhang H; Song B; Zhang B; Wang H
J Exp Clin Cancer Res; 2020 Jun; 39(1):104. PubMed ID: 32513235
[TBL] [Abstract][Full Text] [Related]
16. FGF9/FGFR2 increase cell proliferation by activating ERK1/2, Rb/E2F1, and cell cycle pathways in mouse Leydig tumor cells.
Chang MM; Lai MS; Hong SY; Pan BS; Huang H; Yang SH; Wu CC; Sun HS; Chuang JI; Wang CY; Huang BM
Cancer Sci; 2018 Nov; 109(11):3503-3518. PubMed ID: 30191630
[TBL] [Abstract][Full Text] [Related]
17. Lysine acetyltransferase GCN5 potentiates the growth of non-small cell lung cancer via promotion of E2F1, cyclin D1, and cyclin E1 expression.
Chen L; Wei T; Si X; Wang Q; Li Y; Leng Y; Deng A; Chen J; Wang G; Zhu S; Kang J
J Biol Chem; 2013 May; 288(20):14510-14521. PubMed ID: 23543735
[TBL] [Abstract][Full Text] [Related]
18. A functional SNP in the MDM2 promoter mediates E2F1 affinity to modulate cyclin D1 expression in tumor cell proliferation.
Yang ZH; Zhou CL; Zhu H; Li JH; He CD
Asian Pac J Cancer Prev; 2014; 15(8):3817-23. PubMed ID: 24870800
[TBL] [Abstract][Full Text] [Related]
19. Long Non-Coding RNA LUCAT1 Promotes Proliferation and Invasion in Clear Cell Renal Cell Carcinoma Through AKT/GSK-3β Signaling Pathway.
Zheng Z; Zhao F; Zhu D; Han J; Chen H; Cai Y; Chen Z; Xie W
Cell Physiol Biochem; 2018; 48(3):891-904. PubMed ID: 30032137
[TBL] [Abstract][Full Text] [Related]
20. Up-regulation of miR-181a in clear cell renal cell carcinoma is associated with lower KLF6 expression, enhanced cell proliferation, accelerated cell cycle transition, and diminished apoptosis.
Lei Z; Ma X; Li H; Zhang Y; Gao Y; Fan Y; Li X; Chen L; Xie Y; Chen J; Wu S; Tang L; Zhang X
Urol Oncol; 2018 Mar; 36(3):93.e23-93.e37. PubMed ID: 29066014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
